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Using electronic health records, we assessed the early 
impact of coronavirus disease (COVID-19) on routine 
childhood vaccination in England by 26 April 2020. 
Measles-mumps-rubella vaccination counts fell from 
February 2020, and in the 3 weeks after introduction of 
physical distancing measures were 19.8% lower (95% 
confidence interval: −20.7 to −18.9) than the same 
period in 2019, before improving in mid-April. A grad-
ual decline in hexavalent vaccination counts through-
out 2020 was not accentuated by physical distancing.
Childhood vaccination coverage in the United Kingdom 
(UK) is routinely monitored quarterly, but more timely 
monitoring is required during the disruption of a pan-
demic [1,2]. We analysed electronic patient records 
from primary care to describe changes in delivery of 
first doses of hexavalent vaccine (against diphtheria, 
tetanus, pertussis, polio, Haemophilus influenzae type 
b and hepatitis B) and measles-mumps-rubella (MMR) 
vaccine as part of the routine childhood vaccination 
programme in England during the coronavirus disease 
(COVID-19) outbreak until 26 April 2020 (weeks 1 to 17).
Near real-time records of routine childhood 
vaccinations from primary care
Two key milestones in the routine childhood immuni-
sation programme delivered in primary care are first 
universal vaccinations at the age of 8 weeks, which 
include the hexavalent vaccine, and vaccinations at 
the age of 1 year, which include the first dose of MMR 
vaccine [3].
Aggregated weekly counts of the first hexavalent vac-
cinations delivered to infants younger than 6 months 
and of the first MMR vaccinations delivered to children 
aged 12 to 18 months were provided from The Phoenix 
Partnership (TPP) SystmOne for the first 17 weeks of 
2019 and 2020. SystmOne is a software system which 
provides electronic patient records for more than 
2,600 primary care practices in the UK and more than 
35 child health providers [4]. Age ranges were selected 
to describe vaccinations delivered as part of the rou-
tine vaccination programme rather than catch-up cam-
paigns, and match age ranges for national routine 
surveillance of vaccine coverage [1]. Data were anony-
mous throughout, having been originally extracted as 
aggregated weekly vaccination counts for the purpose 
of SystmOne data checks which use population level 
data.
To minimise changes in denominator, only providers 
active in SystmOne since 2018 contributed to the data-
set. The majority of vaccinations entered into SystmOne 
are entered by general practices in real time. However, 
vaccinations delivered in general practices which use 
other patient record software may be recorded at a 
delay into the SystmOne integrated patient record 
by local Child Health systems co-ordinating vaccina-
tion scheduling. To avoid artefacts from lags in data 
recording, we included only vaccinations recorded on 
the same day as they were delivered (which comprised 
more than 70% of the total hexavalent and MMR vac-
cination doses recorded as delivered in weeks 1 to 17 
of 2019).
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For weeks 1 to 17, the dataset included 69,568 hexava-
lent doses delivered in 2019 and 67,116 in 2020 as well 
as 68,849 MMR doses delivered in 2019 and 66,301 in 
2020.
Ethical statement
This analysis was conducted as part of public health 
usual practice, and was not conducted for research. 
Ethics approval was therefore not sought.
How did vaccination counts change during 
the COVID-19 pandemic?
Hexavalent vaccination counts followed a similar pat-
tern in 2020 as in 2019, varying week by week; particu-
larly low counts in week 1 of both years are probably 
explained by holidays (Figure 1). The MMR vaccination 
counts also followed a similar pattern in 2020 until 
week 11, when they fell, and remained low for several 
weeks before rising again in weeks 16 and 17.
The percent change in vaccinations counts in 2020 com-
pared with 2019 varied over the course of the COVID-19 
pandemic (Table). At the start of 2020 (weeks 1 to 9), 
hexavalent vaccination was 5.8% lower (95% confi-
dence interval (CI): −6.0 to −5.5) and MMR vaccination 
1.0% lower (95% CI: −1.1 to −0.9) compared with 2019.
Weeks 10 to 12 were a transition period, with public 
discussion of physical distancing from at least week 
10 [5]. On 12 March (week 11), the UK government 
advised that anyone with a new continuous cough or a 
fever should self-isolate for 7 days. Physical distancing 
measures were introduced nationally on 20 March (end 
of week 12) and subsequently extended on 23 March 
(start of week 13), closing schools and requiring eve-
ryone in the UK to avoid gatherings and non-essential 
use of public transport, limit contact with others and 
work from home if possible [6]. In weeks 10 to 12 of 
2020, hexavalent vaccination was 4.4% lower (95% CI: 
−4.8 to −4.0) and MMR vaccination 7.2% lower (95% 
CI: −7.7 to −6.7) than in 2019.
In the 3 weeks after introduction of full physical dis-
tancing measures (weeks 13 to 15), hexavalent vac-
cination was 6.7% lower (95% CI: −7.1 to −6.2) and 
MMR vaccination 19.8% lower (95% CI: −20.7 to −18.9) 
than in 2019. Although physical distancing measures 
remained unchanged nationally throughout the rest 
of the study period, vaccination counts were higher in 
weeks 16 and 17 of 2020 than for the same weeks in 
2019, for both vaccines.
Trends over time in the percent change of vaccination 
counts in 2020 compared with 2019 were modelled 
using Joinpoint regression (version 4.8.0.0), which 
finds the best fit for points of change in trend [7]. For 
the hexavalent vaccination, this suggested a general 
decrease in vaccination throughout weeks 1 to 15 in 
2020 compared with the same weeks in 2019, which 
did not accentuate on introduction of physical distanc-
ing, but reversed in week 15, with a percent increase in 
weeks 16 and 17 of 2020 compared with 2019 (Figure 
2). The percent change of first MMR doses delivered in 
2020 compared with 2019 was steady until week 9, but 
then decreased to a low point of −24.2% (95% CI −25.9 
to −22.5%) in week 13 before also reversing, with a 
percent increase in weeks 16 and 17 of 2020 compared 
with 2019 (Figure 2).
How did changes in vaccination counts vary 
geographically?
In the 3 weeks following introduction of physical dis-
tancing measures (weeks 13–15), the percent change 
in hexavalent vaccination in 2020 compared with 2019 
varied by region, ranging from increases of +17.4% 
(95% CI: 12.4 to 22.4) in Cheshire and Merseyside to 
decreases of more than −10% in Greater Manchester, 
London, the West Midlands and Yorkshire and the 
Humber. In contrast, MMR vaccination during weeks 
13 to 15 was lower in 2020 than 2019 for all regions. 
The size of the percent decrease varied, with the great-
est falls in London, Greater Manchester, and the West 
Midlands (Figure 3). By week 17 of 2020, the percent 
Figure 1
Hexavalent and measles-mumps-rubella weekly vaccination counts, England, weeks 1–17, 2019 and 2020
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change in vaccination counts in 2020 compared with 
2019 had improved in all regions, but only two regions 
had reached the cumulative vaccination count seen in 
week 17 of 2019.
Discussion
MMR vaccination started falling in 2020 before intro-
duction of physical distancing measures implemented 
in response to the COVID-19 epidemic. In the first 3 
weeks of physical distancing, MMR vaccination counts 
were 19.8% lower (95% CI: −20.7 to −18.9) than for the 
same period in 2019. There was a general decrease in 
hexavalent vaccinations delivered in 2020 compared 
with 2019, but no evidence of an increase in the rate 
of decline with the introduction of physical distancing 
measures. Counts of both vaccinations increased in 
weeks 16 and 17, despite physical distancing measures 
remaining in place.
One plausible explanation is that COVID-19 messaging 
about staying home initially overwhelmed the mes-
sage that the immunisation programme was to remain 
operating as usual. In England, this appears to have 
affected MMR vaccination more than primary infant 
vaccinations, and qualitative work is underway to 
explore the reasons for this. The message to continue 
routine immunisation programmes became more vis-
ible when the Joint Committee for Immunisation and 
Vaccination published a statement in week 16, on 17 
April [8]. The relative increase in week 16 of 2020 com-
pared with 2019 could partly be attributed to a low vac-
cination count in 2019 because of school holidays – a 
similar decrease was seen in the same week in 2018 
and 2017. This effect may have been less relevant in 
2020 when schools were closed from week 13 and it 
was not possible to go on holidays because of the lock-
down. However, a percent increase was also observed 
in week 17 for both vaccinations. This is promising for 
an early recovery in vaccination delivery following the 
encouragement to continue vaccinating, but will need 
monitoring to ensure it is sustained.
Our findings are consistent with reports of decreased 
vaccine counts in other high-income countries [9,10]. 
In particular, in the United States, routine paediatric 
vaccine counts decreased after a national emergency 
was declared on 13 March, and have recovered some-
what for measles-containing vaccinations to children 
younger than 2 years, which the authors suggest could 
reflect promotion of childhood vaccinations in the con-
text of the pandemic for this age-group [11].
National physical distancing guidance applied across 
all regions, but the impact of the pandemic and physi-
cal distancing may vary by region, either as a result 
of a varying burden of disease (reducing healthcare 
capacity or preventing attendance), behavioural 
change (including physical distancing measures) or 
Table
Hexavalent and measles-mumps-rubella vaccination counts in 2020 compared with 2019, by week, England, weeks 1–17
Week
Hexavalent vaccine first dose MMR vaccine first dose
2019 
 
n
2020 
 
n
Percent change 
 
% (95% CI)a
2019 
 
n
2020 
 
n
Percent change 
 
% (95% CI)a
1 3,191 1,835 −42.5 (−45.2 to −39.8) 2,564 1,515 −40.9 (−43.9 to −38.0)
2 5,447 5,441 −0.1 (−0.2 to 0.0) 5,098 4,935 −3.2 (−3.7 to −2.7)
3 4,720 4,591 −2.7 (−3.2 to −2.3) 5,005 5,170 3.3 (2.8 to 3.8)
4 4,426 4,418 −0.2 (−0.3 to −0.1) 4,893 5,246 7.2 (6.5 to 8.0)
5b 4,185 4,134 −1.2 (−1.6 to −0.9) 4,292 4,445 3.6 (3.0 to 4.1)
6 4,168 3,895 −6.5 (−7.4 to −5.7) 3,988 4,029 1.0 (0.7 to 1.3)
7 4,229 4,114 −2.7 (−3.2 to −2.2) 3,940 3,920 −0.5 (−0.7 to 1.3)
8 3,676 3,497 −4.9 (−5.6 to −4.1) 3,839 3,943 2.7 (2.1 to 3.2)
9 4,051 3,974 −1.9 (−2.3 to −1.5) 4,241 4,278 0.9 (0.6 to 1.2)
10 4,151 4,075 −1.8 (−2.2 to −1.4) 4,262 4,057 −4.8 (−5.5 to −4.1)
11 4,180 3,981 −4.8 (−5.4 to −4.1) 4,010 3,906 −2.6 (−3.1 to −2.1)
12b 3,967 3,704 −6.6 (−7.5 to −5.8) 3,905 3,332 −14.7 (−16.0 to −13.4)
13b 3,855 3,657 −5.1 (−5.9 to −4.4) 3,990 3,024 −24.2 (−25.9 to −22.5)
14 4,039 3,882 −3.9 (−4.5 to −3.3) 4,079 3,345 −18.0 (−19.4 to −16.6)
15 4,030 3,591 −10.9 (−12.0 to −9.8) 3,975 3,290 −17.2 (−18.6 to −15.8)
16 3,469 3,912 12.8 (11.7 to 13.9) 3,227 3,356 4.0 (3.3 to 4.7)
17 3,784 4,415 16.7 (15.5 to 17.9) 3,541 4,510 27.4 (25.9 to 28.8)
Total 69,568 67,116 −3.5 (−3.7 to −3.4) 68,849 66,301 −3.7 (−3.8 to −3.6)
CI: confidence interval; MMR: measles-mumps-rubella.
a 95% CI calculated using the Wilson method.
b Events in 2020 included: World Health Organization declares Public Health Emergency of International Concern on 30 January (week 5); and 
successive introduction of physical distancing measures in the United Kingdom on 20 and 23 March (weeks 12 and 13).
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Figure 2
Percent change in hexavalent and measles-mumps-rubella vaccination in 2020 compared with 2019, by weeka, England, 
weeks 1–17
A. Hexavalent vaccine (n = 69,568 in 2019, 
     n = 67,116 in 2020)
B. Measles-mumps-rubella vaccine (n = 68,849 in 2019, 
     n = 66,301 in 2020)
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Figure 3
Percent change in MMR vaccination counts in the first three weeks of physical distancing (weeks 13 to 15) of 2020 
compared with 2019, by region
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local initiatives to enable vaccination to continue. The 
greatest percent decrease in MMR vaccination in weeks 
13 to 15 was seen in London, which had a high burden 
of COVID-19, but decreases in MMR vaccination were 
seen across all regions in this period, including regions 
with a low incidence of COVID-19 infection, suggest-
ing that the changes were not solely due to COVID-19 
infection burden. SystmOne use varies regionally but 
it is unlikely that software system choice would result 
in vaccination counts being unrepresentative within 
regions [12].
A limitation of this analysis is that changing counts 
of delivered vaccinations could be driven by num-
bers of eligible infants rather than vaccine cover-
age. Decreasing birth rates may plausibly explain the 
overall reduction in counts of both vaccines in 2020 
compared with 2019 [13], and migration could play a 
role too, but these cannot explain the size and tim-
ing of the changes in MMR vaccination during weeks 
10 to 17 of 2020. Deferral of data entry could explain 
some decrease in real-time vaccination counts, but not 
the subsequent increase. Comparison of vaccination 
counts in 2020 to 2019 could also be affected by any 
changes in vaccine coverage in 2019. National quar-
terly surveillance of hexavalent and first MMR vaccine 
coverage from 2017 to 2019 suggests that 2019 was 
unexceptional [2]. Over the long term, there has been 
a gradual but steady decline in childhood vaccine cov-
erage, with a total decrease of ca 2% over the past 5 
years for both vaccines [1]. While it is plausible that this 
trend has continued in 2020, the speed and magnitude 
of changes seen with MMR doses cannot be explained 
by these trends.
Conclusion
It is vital that routine childhood vaccinations are timely, 
particularly for diseases such as measles for which a 
high coverage is required to prevent outbreaks [8,14]. 
The Regional Office for Europe of the World Health 
Organization has advised that routine immunisation 
services should continue to aim for high population 
immunity [15]. Countries will require immunisation 
recovery plans with innovative approaches to deliv-
ery that maintain physical distancing requirements. 
We report the impact of COVID childhood vaccinations 
delivered in primare care, but other vaccinations which 
are routinely delivered in schools (HPV, MenACWY, Td/
IPV) have been interrupted by school closures, and will 
also require catch-up programmes. Continuous and 
timely assessment of vaccine coverage will be required 
to respond to potentially volatile changes during the 
COVID-19 pandemic.
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